# FDA Inspection 1235016 - Cosco Enterprises Inc. - March 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/cosco-enterprises-inc/1aacd4a9-d370-4d68-bcf0-543941312da2
Source feed: FDA_Inspections

> FDA Inspection 1235016 for Cosco Enterprises Inc. on March 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235016
- Company Name: Cosco Enterprises Inc.
- Inspection Date: 2024-03-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 989528 - 2016-10-27](https://www.keypedia.com/records/fda_inspections/cosco-enterprises-inc/cf29c57a-5770-47a0-9bbf-8beaf535d82d)
- [FDA Inspection 731950 - 2011-06-28](https://www.keypedia.com/records/fda_inspections/cosco-enterprises-inc/9ba97bdc-44c0-4ff4-a243-ca3104b93904)
- [FDA Inspection 656105 - 2010-04-06](https://www.keypedia.com/records/fda_inspections/cosco-enterprises-inc/c40ddba0-88b6-430b-846d-1eee6f224d7a)
- [FDA Inspection 656105 - 2010-04-06](https://www.keypedia.com/records/fda_inspections/cosco-enterprises-inc/8dd84a97-ecf4-40a2-a15f-187a979b1cff)

Company: https://www.keypedia.com/companies/cosco-enterprises-inc/de61210e-9051-44b4-b9de-468f8dbfd56d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c